bullish
Kintor Pharma (开拓药业) IPO: Weak in Cornerstone but Still Expect Upside
443 Views12 May 2020 10:19
Kintor Pharma launched book building today to raise up to USD 240 million to listing in Hong Kong. Book will be closed swiftly on Friday. In our...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Kintor Pharmaceutical (9939 HK) – Dual Play on COVID and Solid Tumors02 Oct 2021
- Kintor Pharma (开拓药业) Placement - Still Riding the COVID Momentum26 May 2021
- Kintor Pharma (开拓药业) IPO Trading: Limited Upside Despite Retail Chasing21 May 2020
- Kintor Pharma (开拓药业) Pre-IPO: Post Hearing Updates and Efficacy of Reference Products03 May 2020
- Kintor Pharma (开拓药业) Pre-IPO: Thoughts on Valuation25 Mar 2020
x